Every conversation I have with enterprise leaders today carries an unmistakable urgency about AI transformation. The economics have changed, possibilities have expanded dramatically, and the pressure ...

Most Rust developers are satisfied with the pace of the language’s evolution, but many are concerned Rust does not get enough usage in tech, the 2025 State of Rust Survey says.

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

Contract drug manufacturer OneSource Specialty Pharma received approval for its generic version of Ozempic in Saudi Arabia, clearing the path for selling the type-2 diabetes and weight-loss drug with ...

TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...

The FDA has lost no time in approving the first drug under its recently launched Commissioner's National Priority Voucher (CNPV) programme, clearing an antibiotic manufactured in the US. The fast ...

In the ongoing litigation over Apotex's generic version of GlaxoSmithKline's (GSK) antidepressant paroxetine hydrochloride (Paxil), the US Federal Circuit Appeals Court has reversed the previous ...

Union Commerce Minister Piyush Goyal on Saturday confirmed that India has reached a framework for an interim agreement with the United States. In a joint statement, the two countries said that they ...

Novartis said it expected a key profitability metric to decline this year in large part due to increased competition in the U.S. from generic drug competitors. The Swiss pharma major said Wednesday ...

Jennifer Christian-Herman ( [email protected]) is associate director, Health Services Research, at Cerner Health Insights in Beverly Hills, California. Matthew Emons is a principal investigator there, ...